Abstract
The aim of the study was to design and validate a reversed phase high performance liquid chromatography method for the separation and quantification of two active pharmaceutical ingredients (ciprofloxacin hydrochloride, hydrocortisone) and a preservative (benzyl alcohol) in ear drops. Effective separation of the examined compounds was achieved on a GraceSmart™ RP 18 column (150 mm × 4.6 mm, 5 μm) with gradient elution and a diode array detector. The total assay run time was 25 min. Analytical method validation assays were performed. Validation parameters used for the evaluation were: specificity, linearity, trueness, precision (repeatability and reproducibility), limit of detection and limit of quantitation. Results of the validation procedure (high recoveries, good standard deviations, no interfering peaks at the retention times corresponding to the analytes) confirm that the developed chromatographic method can be applied for routine analysis of ear drops.
[1] Aksoy, B., Küçükgüzel, İ., & Rollas, S. (2007). Development and validation of a stability-indicating HPLC method for determination of ciprofloxacin hydrochloride and its related compounds in film-coated tablets. Chromatographia, 66(Supplement), 57–63. DOI: 10.1365/s10337-007-0287-6. http://dx.doi.org/10.1365/s10337-007-0287-610.1365/s10337-007-0287-6Search in Google Scholar
[2] Becvaroski, Z., Kartush, J. M., & Bojrab, D. I. (2002). Intratympanic ciprofloxacin and the human labyrinthine sampling model. The Laryngoscope, 112, 686–688. DOI: 10.1097/00005537-200204000-00017. http://dx.doi.org/10.1097/00005537-200204000-0001710.1097/00005537-200204000-00017Search in Google Scholar
[3] Brownlee, R. E., Hulka, G. F., Prazma, J., & Pillsbury, H. C. (1992). Ciprofloxacin use as a topical otic preparation. Archives of Otolaryngology — Head and Neck Surgery, 118, 392–396. DOI: 10.1001/archotol.1992.01880040050009. http://dx.doi.org/10.1001/archotol.1992.0188004005000910.1001/archotol.1992.01880040050009Search in Google Scholar
[4] Claes, J., Govaerts, P. J., Van de Heyning, P. H., & Peeters, S. (1991). Lack of ciprofloxacin ototoxicity after repeated ototopical application. Antimicrobial Agents and Chemotherapy, 35, 1014–1016. DOI: 10.1128/aac.35.5.1014. http://dx.doi.org/10.1128/AAC.35.5.101410.1128/AAC.35.5.1014Search in Google Scholar
[5] Gowda, B. G., & Seetharamappa, J. (2003). Extractive spectrophotometric determination of fluoroquinolones and antiallergic drugs in pure and pharmaceutical formulations. Analytical Sciences, 19, 461–464. DOI: 10.2116/analsci.19.461. http://dx.doi.org/10.2116/analsci.19.46110.2116/analsci.19.461Search in Google Scholar
[6] ICH (1999). Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances. Geneva, Switzerland: The International Conference on Harmonisation. Search in Google Scholar
[7] ISO (1996). Linear calibration using reference materials. Standard: ISO 11095:1996. Geneva, Switzerland: International Organization for Standardization. Search in Google Scholar
[8] İkiz, A. Ö., Şerbetçioğlu, B., Güneri, E. A., Sütay, S., & Ceryan, K. (1998). Investigation of topical ciprofloxacin ototoxicity in guinea pigs. Acta Otolaryngologica, 118, 808–812. DOI: 10.1080/00016489850182486. http://dx.doi.org/10.1080/0001648985018248610.1080/00016489850182486Search in Google Scholar
[9] Klinsunthorn, N., Petsom, A., & Nhujak, T. (2011). Determination of steroids adulterated in liquid herbal medicines using QuEChERS sample preparation and high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 55, 1175–1178. DOI: 10.1016/j.jpba.2011.03.046. http://dx.doi.org/10.1016/j.jpba.2011.03.04610.1016/j.jpba.2011.03.046Search in Google Scholar
[10] Mahrouse, M. A., & Elkady, E. F. (2011). Validated spectrophotometric methods for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in tablets. Chemical and Pharmacetical Bulletin, 59, 1485–1493. DOI: 10.1248/cpb.59.1485. http://dx.doi.org/10.1248/cpb.59.148510.1248/cpb.59.1485Search in Google Scholar
[11] Morizono, T., Paparella, M. M., & Juhn, S. K. (1980). Ototoxicity of propylene glycol in experimental animals. American Journal of Otolaryngology, 1, 393–399. DOI: 10.1016/s0196-0709(80)80020-2. http://dx.doi.org/10.1016/S0196-0709(80)80020-210.1016/S0196-0709(80)80020-2Search in Google Scholar
[12] Purwar, S., & Goldman, D. (1999). US Patent No. 5,965,549. Washington, DC, USA: US Patent Office. Search in Google Scholar
[13] Pyka, A., Babuska-Roczniak, M., & Bochenska, P. (2011). Determination of hydrocortisone in pharmaceutical drug by TLC with densitometric detection in UV. Journal of Liquid Chromatography & Related Technologies, 34, 753–769. DOI: 10.1080/10826076.2011.563891. http://dx.doi.org/10.1080/10826076.2011.56389110.1080/10826076.2011.563891Search in Google Scholar
[14] Rohn, G. N., Meyerhoff, W. L., & Wrihgt, C. G. (1993). Ototoxicity of topical agents. Otolaryngologic Clinics of North America, 26, 747–758. 10.1016/S0030-6665(20)30765-9Search in Google Scholar
[15] Roland, P. S., & Rutka, J. A.(2004). Ototoxicity. Hamilton, ON, Canada: BC Decker. Search in Google Scholar
[16] Wall, G. M., Stroman, D.W., Roland, P. S., & Dohar, J. (2009). Ciprofloxacin 0.3 %/dexamethasone 0.1 % sterile otic suspension for the topical treatment of ear infections: A Review of the literature. The Pediatric Infectious Disease Journal, 28, 141–144. DOI: 10.1097/inf.0b013e31818b0c9c. http://dx.doi.org/10.1097/INF.0b013e31818b0c9c10.1097/INF.0b013e31818b0c9cSearch in Google Scholar PubMed
[17] Zhao, L. Z., Guo, Y., Dou, Y., Wang, B., Mi, H., & Ren, Y. L. (2007). Application of artificial neural networks to the nondestructive determination of ciprofloxacin hydrochloride in powder by short-wavelength NIR spectroscopy. Journal of Analytical Chemistry, 62, 1156–1162. DOI: 10.1134/s1061934807120106. http://dx.doi.org/10.1134/S106193480712010610.1134/S1061934807120106Search in Google Scholar
© 2013 Institute of Chemistry, Slovak Academy of Sciences
